Afegostat ( DrugBank: Afegostat )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	4

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00813865 (ClinicalTrials.gov)	May 11, 2009	22/12/2008	A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients	An Open-Label, Multicenter, Long-Term Extension Study To Assess The Safety, Efficacy, And Pharmacody ...	Gaucher Disease;Type 1 Gaucher Disease;Gaucher Disease, Type 1	Drug: afegostat tartrate	Amicus Therapeutics	NULL	Completed	18 Years	N/A	All	8	Phase 2	United States;United Kingdom;Paraguay
2	EUCTR2008-007158-36-GB (EUCTR)	25/02/2009	29/04/2009	An open-label, multicentre, long-term extension study to assess the safety, efficacy and pharmacodyn ...	An open-label, multicentre, long-term extension study to assess the safety, efficacy and pharmacodyn ...	Type I Gaucher Disease MedDRA version: 9.1;Level: LLT;Classification code 10018048;Term: Gaucher's d ...	Product Name: afegostat tartrate Product Code: AT2101 INN or Proposed INN: afegostat tartrate	Amicus Therapeutics, Inc.	NULL	Not Recruiting			Female: yes Male: yes	16		United Kingdom
3	NCT00446550 (ClinicalTrials.gov)	June 11, 2008	9/3/2007	A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease	A Randomized, Open-label Study To Assess the Safety and Tolerability of AT2101 in Treatment-naive Ad ...	Gaucher Disease;Type 1 Gaucher Disease;Gaucher Disease, Type 1	Drug: afegostat tartrate	Amicus Therapeutics	NULL	Completed	18 Years	74 Years	All	19	Phase 2	United States;Israel;South Africa;United Kingdom;Germany
4	NCT00433147 (ClinicalTrials.gov)	March 23, 2007	7/2/2007	A Study of AT2101 (AfegostatTartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiv ...	A Randomized, Open-label Study to Assess the Safety and Tolerability of Multiple Dose Levels and Mul ...	Gaucher Disease, Type 1;Type 1 Gaucher Disease;Gaucher Disease	Drug: Afegostat tartrate	Amicus Therapeutics	NULL	Completed	18 Years	74 Years	All	30	Phase 2	United States

First Previous1Next Last